68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Clinical trial NCT02038738 · UNKNOWN

Trial details

NCT number: NCT02038738
Sponsor: Ochsner Health System
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Neuroendocrine Tumor Neuroendocrine Cancer Neuroendocrine Carcinoma Carcinoid Carcinoid Tumor Islet Cell Tumor Apudoma

Start date: 2014-03-01
Primary completion: 2019-03-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.